UTI vs LINC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

UTI

39.4
AI Score
VS
LINC Wins

LINC

52.6
AI Score

Investment Advisor Scores

UTI

39score
Recommendation
SELL

LINC

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric UTI LINC Winner
Forward P/E 28.4091 26.0417 LINC
PEG Ratio 1.8924 1.7348 LINC
Revenue Growth 7.2% 22.4% LINC
Earnings Growth -78.9% 20.0% LINC
Tradestie Score 39.4/100 52.6/100 LINC
Profit Margin 3.9% 4.0% LINC
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD LINC

Relative Price Performance (Last 90 Days)

UTI 1M: -20.8% · 3M: -50.2% LINC 1M: -16.0% · 3M: -47.4%

Current Technical Phase

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

LINC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.7%), weak momentum, RSI 31

RSI (14): 30.8 · Price: $25.02

Fundamentals Snapshot

Metric UTI LINC
Market Cap
Forward P/E 27.6 23.9
Trailing P/E 34.9 33.4
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.59 0.73
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LINC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.